APA (7th ed.) Citation

H, W., C, L., Q, Y., Y, Q., Y, D., L, D., . . . J, Z. (2023). A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC. Oncoimmunology, 12(1), 2282250. https://doi.org/10.1080/2162402X.2023.2282250

Chicago Style (17th ed.) Citation

H, Wu, et al. "A Novel Fc-enhanced Humanized Monoclonal Antibody Targeting B7-H3 Suppresses the Growth of ESCC." Oncoimmunology 12, no. 1 (2023): 2282250. https://doi.org/10.1080/2162402X.2023.2282250.

MLA (9th ed.) Citation

H, Wu, et al. "A Novel Fc-enhanced Humanized Monoclonal Antibody Targeting B7-H3 Suppresses the Growth of ESCC." Oncoimmunology, vol. 12, no. 1, 2023, p. 2282250, https://doi.org/10.1080/2162402X.2023.2282250.